Repeatability evaluation of PET/CT imaging using [18F]fluorothymidine (FLT) and [18F]fluorodeoxyglucose (FDG) in primary triple negative breast cancer (TNBC)

J. L. Glendenning; S. Barrington; H. Tovey; J. Parikh; J. Dunn; A. Tutt

doi:10.1093/annonc/mdv119.02

Repeatability evaluation of PET/CT imaging using [18F]fluorothymidine (FLT) and [18F]fluorodeoxyglucose (FDG) in primary triple negative breast cancer (TNBC)

J. L. Glendenning, S. Barrington, H. Tovey, J. Parikh, J. Dunn, A. Tutt

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	iii27
Journal	Annals of Oncology
Volume	26
DOIs	https://doi.org/10.1093/annonc/mdv119.02
Publication status	Published - May 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdv119.02

Cite this

@article{965c79c32bbf40469338cb4a8dd03176,

title = "Repeatability evaluation of PET/CT imaging using [18F]fluorothymidine (FLT) and [18F]fluorodeoxyglucose (FDG) in primary triple negative breast cancer (TNBC)",

author = "Glendenning, {J. L.} and S. Barrington and H. Tovey and J. Parikh and J. Dunn and A. Tutt",

year = "2015",

month = may,

doi = "10.1093/annonc/mdv119.02",

language = "English",

volume = "26",

pages = "iii27",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier",

}

TY - JOUR

T1 - Repeatability evaluation of PET/CT imaging using [18F]fluorothymidine (FLT) and [18F]fluorodeoxyglucose (FDG) in primary triple negative breast cancer (TNBC)

AU - Glendenning, J. L.

AU - Barrington, S.

AU - Tovey, H.

AU - Parikh, J.

AU - Dunn, J.

AU - Tutt, A.

PY - 2015/5

Y1 - 2015/5

UR - http://www.scopus.com/inward/record.url?scp=85081666784&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdv119.02

DO - 10.1093/annonc/mdv119.02

M3 - Article

SN - 0923-7534

VL - 26

SP - iii27

JO - Annals of Oncology

JF - Annals of Oncology

ER -

Repeatability evaluation of PET/CT imaging using [18F]fluorothymidine (FLT) and [18F]fluorodeoxyglucose (FDG) in primary triple negative breast cancer (TNBC)

UN SDGs

Access to Document

Other files and links

Cite this